CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
Conference
"HIV/HCV Co-infection" Dr. Shariq Haider (biography) English - 2003-11-11 - 10 minutes
(4 slides)
Summary : Although the EUROSIDA Study showed no role of HCV in accelerating the progression of AIDS, there was a rise observed in liver related deaths in HIV/HCV co-infected patients. Clinical data on peg alpha 2a plus Ribavirin (PRESCO Study), and peg alpha 2b plus Ribavirin (Santos et al) in treatment of HIV/HCV co-infected patients will be discussed here, as well as new information on toxicities associated with IFN or peg-IFN plus Ribavirin (Laguno et al), and finally barriers to treatment of HIV/HCV co-infected patients (Benta et al).
Learning objectives : The participant will learn about new data from the EUROSIDA Study, clinical data on peg alpha 2a and peg alpha 2b, toxicities and side effects of therapy using interferon or pegylated interferon with ribavirin, and barriers to HIV/HCV co-infection treatment.
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
